title: What is the current status of second-line chemotherapy for castration-resistant prostate cancer?
authors.affiliation: Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber CancerInstitute, Boston, MA 02446, USA. jonathan_rosenberg@dfci.harvard.edu
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Rosenberg
authors.forename: William K
authors.initials: WK
authors.lastname: Oh